Risk of thiazide-induced metabolic adverse events in older adults

Journal of the American Geriatrics Society

Volumn 62, Issue 6, 2014, Pages 1039-1045

  Makam, Anil N ^a   John Boscardin, W ^b,c   Miao, Yinghui ^b   Steinman, Michael A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aged adverse effects; hypertension; outcome assessment (health care); sodium chloride symporter inhibitors

Indexed keywords

POTASSIUM; SODIUM; THIAZIDE DIURETIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE DRUG REACTION; AGED; COMORBIDITY; CONFERENCE PAPER; ELECTROLYTE DISTURBANCE; EMERGENCY WARD; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; HYPOKALEMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POTASSIUM BLOOD LEVEL; PREDICTION; RISK; SODIUM BLOOD LEVEL;

AGED, ADVERSE EFFECTS; HYPERTENSION; OUTCOME ASSESSMENT (HEALTH CARE); SODIUM CHLORIDE SYMPORTER INHIBITORS;

AGED; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; FEMALE; HUMANS; MALE; METABOLIC DISEASES; RISK ASSESSMENT; THIAZIDES;

EID: 84902355103     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12839     Document Type: Conference Paper

References (36)

1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
2. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265: 3255-3264.
3. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.
4. Flather M, Delahunty N, Collinson J,. Generalizing results of randomized trials to clinical practice: Reliability and cautions. Clin Trials 2006; 3: 508-512.
5. Kent DM, Hayward RA,. Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification. JAMA 2007; 298: 1209-1212.
6. Ernst ME, Moser M,. Use of diuretics in patients with hypertension. N Engl J Med 2009; 361: 2153-2164.
7. Palmer BF, Naderi AS,. Metabolic complications associated with use of thiazide diuretics. J Am Soc Hypertens 2007; 1: 381-392.
8. Amin A, Deitelzweig S, Christian R, et al. Evaluation of incremental healthcare resource burden and readmission rates associated with hospitalized hyponatremic patients in the US. J Hosp Med 2012; 7: 634-639.
9. Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-Analysis. Am J Kidney Dis 2009; 53: 961-973.
10. Cohen HW, Madhavan S, Alderman MH,. High and low serum potassium associated with cardiovascular events in diuretic-treated patients. J Hypertens 2001; 19: 1315-1323.
11. Franse LV, Pahor M, Di Bari M, et al. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000; 35: 1025-1030.
12. Sajadieh A, Binici Z, Mouridsen MR, et al. Mild hyponatremia carries a poor prognosis in community subjects. Am J Med 2009; 122: 679-686.
13. Shea AM, Hammill BG, Curtis LH, et al. Medical costs of abnormal serum sodium levels. J Am Soc Nephrol 2008; 19: 764-770.
14. Waikar SS, Liu KD, Chertow GM,. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 844-861.
15. Grobbee DE, Hoes AW,. Non-potassium-sparing diuretics and risk of sudden cardiac death. J Hypertens 1995; 13: 1539-1545.
16. Wald R, Jaber BL, Price LL, et al. Impact of hospital-Associated hyponatremia on selected outcomes. Arch Intern Med 2010; 170: 294-302.
17. Alderman MH, Piller LB, Ford CE, et al. Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension 2012; 59: 926-933.
18. Leung AA, Wright A, Pazo V, et al. Risk of thiazide-induced hyponatremia in patients with hypertension. Am J Med 2011; 124: 1064-1072.
19. Beijer HJ, de Blaey CJ,. Hospitalisations caused by adverse drug reactions (ADR): A meta-Analysis of observational studies. Pharm World Sci 2002; 24: 46-54.
20. Mallet L, Spinewine A, Huang A,. The challenge of managing drug interactions in elderly people. Lancet 2007; 370: 185-191.
21. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-Analysis. JAMA 2003; 289: 2534-2544.
22. Wing LM, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-592.
23. Ray WA,. Evaluating medication effects outside of clinical trials: New-user designs. Am J Epidemiol 2003; 158: 915-920.
24. Steinman MA, Lee SJ, John Boscardin W, et al. Patterns of multimorbidity in elderly veterans. J Am Geriatr Soc 2012; 60: 1872-1880.
25. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
26. Rubin DB,. Using propensity scores to help design observational studies: Application to the tobacco litigation. Health Serv Outcomes Res Methodol 2001; 2: 169-188.
27. Dhalla IA, Gomes T, Yao Z, et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: A population-based cohort study. Ann Intern Med 2013; 158: 447-455.
28. Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR risk score. Arch Intern Med 2010; 170: 1142-1148.
29. Chow KM, Szeto CC, Wong TY, et al. Risk factors for thiazide-induced hyponatraemia. QJM 2003; 96: 911-917.
30. Sharabi Y, Illan R, Kamari Y, et al. Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens 2002; 16: 631-635.
31. Ernst ME, Carter BL, Zheng S, et al. Meta-Analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: Effects on systolic blood pressure and potassium. Am J Hypertens 2010; 23: 440-446.
32. Materson BJ, Cushman WC, Goldstein G, et al. Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study. Hypertension 1990; 15: 348-360.
33. Rose BD, Post TW,. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th Ed. New York: McGraw-Hill, 2001.
34. Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119: e1-e8.
35. Musini VM, Tejani AM, Bassett K, et al. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009: CD000028.
36. Sonnenblick M, Friedlander Y, Rosin AJ,. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 1993; 103: 601-606.